Literature DB >> 24866986

Statins in the elderly: an answered question?

Sophia Zoungas1, Andrea Curtis, Andrew Tonkin, John McNeil.   

Abstract

PURPOSE OF REVIEW: A strong potential exists for greater promotion of statin therapy among the over-70 age group on the basis of their high absolute cardiovascular risk. However, the evidence for this approach is currently unclear. RECENT
FINDINGS: Meta-analysis of trials highlights the uncertainty about the efficacy of statins in the prevention of major vascular events and all-cause mortality in the elderly. This stems from inadequate numbers of participants from this age group included in previous randomized clinical trials. Adverse effects of statins are likely to be greater in the elderly, but their frequency is uncertain and their contribution to frailty and loss of independence in the elderly has been little studied.
SUMMARY: Real world trials examining the impact of statin therapy in the elderly are now called for.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24866986     DOI: 10.1097/HCO.0000000000000082

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  4 in total

1.  Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease.

Authors:  Alberto Pilotto; Pietro Gallina; Francesco Panza; Massimiliano Copetti; Alberto Cella; Alfonso Cruz-Jentoft; Julia Daragjati; Luigi Ferrucci; Stefania Maggi; Francesco Mattace-Raso; Marc Paccalin; Maria Cristina Polidori; Eva Topinkova; Gianluca Trifirò; Anna-Karin Welmer; Timo Strandberg; Niccolò Marchionni
Journal:  Am J Cardiol       Date:  2016-08-30       Impact factor: 2.778

2.  Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review.

Authors:  Richard Ofori-Asenso; Ella Zomer; Andrea Curtis; Andrew Tonkin; Mark Nelson; Manoj Gambhir; Danny Liew; Sophia Zoungas
Journal:  JMIR Res Protoc       Date:  2017-03-07

3.  Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes Audit.

Authors:  Natalie Nanayakkara; Sanjeeva Ranasinha; Adelle M Gadowski; Wendy A Davis; Jeffrey Ronald Flack; Natalie Wischer; Sof Andrikopoulos; Sophia Zoungas
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692

4.  The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients.

Authors:  Adam J Hodgkins; Judy Mullan; Darren Mayne; Andrew Bonney
Journal:  Pharmacy (Basel)       Date:  2019-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.